Resveratrol inhibits proliferation of primary rat hepatocytes in G0/G1 by inhibiting DNA synthesis. 2012

J A Rubiolo, and H López-Alonso, and V Martín-Vázquez, and N M Fol-Rodríguéz, and M R Vieytes, and L M Botana, and F V Vega
Departamento de Fisiología, Facultad de Veterinaria, Universidad de Santiago de Compostela, Lugo, Spain. ja.rubiolo@usc.es

Resveratrol is a phytoalexin that has been shown to inhibit cell proliferation of several cancer cell lines. In some cases this inhibition was specific for the transformed cells when compared with normal cells of the same tissue. To test whether this was the case in rat hepatocytes, we exposed primary rat hepatocytes in culture and transformed rat hepatic cells to this compound and studied its effect on cell proliferation, measuring deoxy-bromouridine incorporation and total DNA. We also studied the effect of resveratrol on the cell cycle of normal and transformed rat hepatocytes. We observed that resveratrol inhibited proliferation in a dose-dependent manner in both cases, with no differential action in the transformed cells compared to the normal ones. This compound arrested the cell cycle in G0/G1 in primary hepatocytes, while it arrested the cell cycle in G2/M in transformed cells. Transformed hepatocytes showed accumulation of cells in the S phase of the cell cycle.

UI MeSH Term Description Entries
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077185 Resveratrol A stilbene and non-flavonoid polyphenol produced by various plants including grapes and blueberries. It has anti-oxidant, anti-inflammatory, cardioprotective, anti-mutagenic, and anti-carcinogenic properties. It also inhibits platelet aggregation and the activity of several DNA HELICASES in vitro. 3,4',5-Stilbenetriol,3,4',5-Trihydroxystilbene,3,5,4'-Trihydroxystilbene,Resveratrol, (Z)-,Resveratrol-3-sulfate,SRT 501,SRT-501,SRT501,cis-Resveratrol,trans-Resveratrol,trans-Resveratrol-3-O-sulfate,Resveratrol 3 sulfate,cis Resveratrol,trans Resveratrol,trans Resveratrol 3 O sulfate
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D013267 Stilbenes Organic compounds that contain 1,2-diphenylethylene as a functional group. Stilbene,Stilbene Derivative,Stilbene Derivatives,Stilbenoid,Stilbenoids,Derivative, Stilbene,Derivatives, Stilbene
D016192 Resting Phase, Cell Cycle A quiescent state of cells during G1 PHASE. G0 Phase,G0 Phases,Phase, G0,Phases, G0

Related Publications

J A Rubiolo, and H López-Alonso, and V Martín-Vázquez, and N M Fol-Rodríguéz, and M R Vieytes, and L M Botana, and F V Vega
December 2020, Medicina (Kaunas, Lithuania),
J A Rubiolo, and H López-Alonso, and V Martín-Vázquez, and N M Fol-Rodríguéz, and M R Vieytes, and L M Botana, and F V Vega
May 2004, Cancer research,
J A Rubiolo, and H López-Alonso, and V Martín-Vázquez, and N M Fol-Rodríguéz, and M R Vieytes, and L M Botana, and F V Vega
December 1995, Mutation research,
J A Rubiolo, and H López-Alonso, and V Martín-Vázquez, and N M Fol-Rodríguéz, and M R Vieytes, and L M Botana, and F V Vega
March 2009, European journal of clinical investigation,
J A Rubiolo, and H López-Alonso, and V Martín-Vázquez, and N M Fol-Rodríguéz, and M R Vieytes, and L M Botana, and F V Vega
September 2000, European journal of pharmacology,
J A Rubiolo, and H López-Alonso, and V Martín-Vázquez, and N M Fol-Rodríguéz, and M R Vieytes, and L M Botana, and F V Vega
January 2016, Oncology research,
J A Rubiolo, and H López-Alonso, and V Martín-Vázquez, and N M Fol-Rodríguéz, and M R Vieytes, and L M Botana, and F V Vega
April 1983, Biochemistry,
J A Rubiolo, and H López-Alonso, and V Martín-Vázquez, and N M Fol-Rodríguéz, and M R Vieytes, and L M Botana, and F V Vega
June 1998, Hepatology (Baltimore, Md.),
J A Rubiolo, and H López-Alonso, and V Martín-Vázquez, and N M Fol-Rodríguéz, and M R Vieytes, and L M Botana, and F V Vega
November 2017, Experimental and therapeutic medicine,
J A Rubiolo, and H López-Alonso, and V Martín-Vázquez, and N M Fol-Rodríguéz, and M R Vieytes, and L M Botana, and F V Vega
November 1990, Mutation research,
Copied contents to your clipboard!